`Q5138` Inj, wezlana, iv, 1 mg

Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg

Medicare coverage: Carrier judgment
Status: active (July 2026 file)
MUE: max 520 units per day (practitioner), rationale: Prescribing Information